Medications in Management of Osteoporosis: Combination Therapy
- Combination therapy, usually using a bisphosphonate with another anti-osteoporotic agent, can provide additional small increases in BMD when compared with mono-therapy. The impact of combination therapy on fracture rates is unknown. The added cost and potential side effects should be weighed against potential gains.
